journal article·2024-01-08

Cobalt and Chromium Ions Impair Macrophage Response to Staphylococcus aureus Infection

Lea A. Tölken, Georgi I. Wassilew, Daniel Grolimund, Timm Weitkamp, Bernhard Hesse, Anastasia Rakow, Nikolai Siemens, Janosch Schoon

Publisher page

Abstract

Cobalt–chromium–molybdenum (CoCrMo) alloys are routinely used in arthroplasty. CoCrMo wear particles and ions derived from arthroplasty implants lead to macrophage-driven adverse local tissue reactions, which have been linked to an increased risk of periprosthetic joint infection after revision arthroplasty. While metal-induced cytotoxicity is well characterized in human macrophages, direct effects on their functionality have remained elusive. Synchrotron radiation X-ray microtomography and X-ray fluorescence mapping indicated that peri-implant tissues harvested during aseptic revision of different arthroplasty implants are exposed to Co and Cr in situ. Confocal laser scanning microscopy revealed that macrophage influx is predominant in patient tissue. While in vitro exposure to Cr 3+ had only minor effects on monocytes/macrophage phenotype, pathologic concentrations of Co 2+ significantly impaired both, monocyte/macrophage phenotype and functionality. High concentrations of Co 2+ led to a shift in macrophage subsets and loss of surface markers, including CD14 and CD16. Both Co 2+ and Cr 3+ impaired macrophage responses to Staphylococcus aureus infection, and particularly, Co 2+ -exposed macrophages showed decreased phagocytic activity. These findings demonstrate the immunosuppressive effects of locally elevated metal ions on the innate immune response and support further investigations, including studies exploring whether Co 2+ and Cr 3+ or CoCrMo alloys per se expose the patients to a higher risk of infections post-revision arthroplasty.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Orthopedic Infections and Treatments · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Molecular Genetics and Infection Biology, University of Greifswald, Greifswald 17489,Germany

Center for Orthopaedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Greifswald 17475, Germany

Swiss Light Source, Paul Scherrer Institute, Villigen-PSI 5232, Switzerland

Synchrotron SOLEIL, Saint-Aubin 91190, France

Xploraytion GmbH, Berlin 10625, Germany

ESRF-The European Synchrotron, Grenoble 38000, France

Funding

Agence Nationale de la Recherche · Deutsche Forschungsgemeinschaft

References (67)

Show source-provided references
1. 10.1016/j.jot.2022.10.01310.1016/j.jot.2022.10.013 ↗
2. 10.1302/2058-5241.6.21001310.1302/2058-5241.6.210013 ↗
3. 10.1016/j.biomaterials.2004.08.00410.1016/j.biomaterials.2004.08.004 ↗
4. 10.3389/fbioe.2019.0017610.3389/fbioe.2019.00176 ↗
5. 10.3109/17435390.2014.99143010.3109/17435390.2014.991430 ↗
6. 10.1016/j.actbio.2020.03.01710.1016/j.actbio.2020.03.017 ↗
7. 10.3389/fmats.2020.0027410.3389/fmats.2020.00274 ↗
8. 10.1016/j.arth.2020.02.00610.1016/j.arth.2020.02.006 ↗
9. 10.1007/s11999-013-2979-610.1007/s11999-013-2979-6 ↗
10. 10.1302/0301-620X.96B12.3347310.1302/0301-620X.96B12.33473 ↗
11. 10.1007/s11999.000000000000002910.1007/s11999.0000000000000029 ↗
12. 10.1302/0301-620X.91B8.2256210.1302/0301-620X.91B8.22562 ↗
13. 10.1007/s11999-013-3157-610.1007/s11999-013-3157-6 ↗
14. 10.1016/j.jcot.2019.09.02110.1016/j.jcot.2019.09.021 ↗
15. 10.1302/2046-3758.67.BJR-2017-0017.R210.1302/2046-3758.67.BJR-2017-0017.R2 ↗
16. 10.1007/s00132-023-04352-y10.1007/s00132-023-04352-y ↗
17. 10.1002/advs.20200041210.1002/advs.202000412 ↗
18. 10.1016/j.actbio.2019.05.07110.1016/j.actbio.2019.05.071 ↗
19. 10.1016/j.biomaterials.2016.04.02310.1016/j.biomaterials.2016.04.023 ↗
20. 10.1016/j.wear.2014.12.03010.1016/j.wear.2014.12.030 ↗
21. 10.1007/s10856-022-06675-210.1007/s10856-022-06675-2 ↗
22. 10.1016/j.jor.2020.08.01910.1016/j.jor.2020.08.019 ↗
23. 10.1055/a-1187-175110.1055/a-1187-1751 ↗
24. 10.3109/15563650.2014.94497710.3109/15563650.2014.944977 ↗
25. 10.1302/2058-5241.4.18009210.1302/2058-5241.4.180092 ↗
26. 10.1111/iwj.1264010.1111/iwj.12640 ↗
27. 10.2106/JBJS.19.0053710.2106/JBJS.19.00537 ↗
28. Renz, N.; Trampuz, A.; Perka, C.; Rakow, A. In Outcome and Failure Analysis of 132 Episodes of Hematogenous Periprosthetic Joint Infections─A Cohort Study, Open Forum Infectious Diseases; Oxford University Press US, 2022; p ofac094.10.1093/ofid/ofac094 ↗
29. 10.1080/17453674.2020.185153310.1080/17453674.2020.1851533 ↗
30. 10.1016/j.arth.2018.05.04210.1016/j.arth.2018.05.042 ↗
31. 10.1097/INF.000000000000163510.1097/INF.0000000000001635 ↗
32. 10.1128/CMR.00134-1410.1128/CMR.00134-14 ↗
33. 10.1016/j.arth.2023.02.06110.1016/j.arth.2023.02.061 ↗
34. 10.1056/NEJMra220347710.1056/NEJMra2203477 ↗
35. 10.1128/CMR.00111-1310.1128/CMR.00111-13 ↗
36. 10.3390/jcm805067310.3390/jcm8050673 ↗
37. 10.1016/j.cmi.2021.06.00610.1016/j.cmi.2021.06.006 ↗
38. 10.1016/j.cmi.2018.04.03510.1016/j.cmi.2018.04.035 ↗
39. 10.1002/jbm.a.3459910.1002/jbm.a.34599 ↗
40. 10.1146/annurev-pathmechdis-012418-01271810.1146/annurev-pathmechdis-012418-012718 ↗
41. 10.1111/imr.1222410.1111/imr.12224 ↗
42. 10.1093/toxsci/kfr12410.1093/toxsci/kfr124 ↗
43. 10.1016/j.actbio.2018.03.05410.1016/j.actbio.2018.03.054 ↗
44. 10.1088/1742-6596/2380/1/01212210.1088/1742-6596/2380/1/012122 ↗
45. 10.1088/1742-6596/849/1/01203710.1088/1742-6596/849/1/012037 ↗
46. 10.1016/j.sab.2006.12.00210.1016/j.sab.2006.12.002 ↗
47. Wick, M. R. In The hematoxylin and eosin stain in anatomic pathology─An often-neglected focus of quality assurance in the laboratory, Seminars in diagnostic pathology; Elsevier, 2019; pp 303–311.10.1053/j.semdp.2019.06.003 ↗
48. 10.1093/infdis/jiz16710.1093/infdis/jiz167 ↗
49. 10.1038/srep3136010.1038/srep31360 ↗
50. Krenn V. · 2017 · 110.1007/978-3-662-54204-0 ↗
51. 10.3390/ma1305115010.3390/ma13051150 ↗
52. 10.1016/j.nano.2017.08.00410.1016/j.nano.2017.08.004 ↗
53. 10.1016/j.nano.2016.11.00310.1016/j.nano.2016.11.003 ↗
54. 10.1186/s12907-018-0074-310.1186/s12907-018-0074-3 ↗
55. 10.1016/j.biomaterials.2015.07.03410.1016/j.biomaterials.2015.07.034 ↗
56. 10.1023/A:100887852723310.1023/A:1008878527233 ↗
57. 10.3390/lubricants303053910.3390/lubricants3030539 ↗
58. 10.1038/srep0572910.1038/srep05729 ↗
59. Yoshioka N. · Anticancer Res. · 2009 · 29 · 865
60. 10.1016/j.tiv.2014.11.00610.1016/j.tiv.2014.11.006 ↗
61. 10.1074/jbc.270.43.2576210.1074/jbc.270.43.25762 ↗
62. 10.1128/JCM.42.10.4846-4849.200410.1128/JCM.42.10.4846-4849.2004 ↗
63. Lu, Y.; Cai, W.J.; Ren, Z.; Han, P. The Role of Staphylococcal Biofilm on the Surface of Implants in Orthopedic Infection Microorganisms [Online], 2022.10.3390/microorganisms10101909 ↗
64. 10.1371/journal.ppat.100835410.1371/journal.ppat.1008354 ↗
65. 10.3109/17453674.2014.96629010.3109/17453674.2014.966290 ↗
66. 10.1172/JCI11130510.1172/JCI111305 ↗
67. 10.1093/infdis/146.4.48710.1093/infdis/146.4.487 ↗